{"id":432103,"title":"Statement on the classification of insulin products and duration of action: Notice to stakeholders - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T07:15:57.732000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/statement-classification-insulin-products-duration-action-notice-stakeholders.html","snippet":"Statement on the classification of insulin products and duration of action: Notice to stakeholders Date published: August 6, 2020 Issue After conducting a class review of Product Monographs for various insulin products authorized in Canada over time, Health Canada has concluded…","rawSnapshotUrl":"/api/snapshots/raw/432103","browseUrl":"https://replay.healtharchive.ca/job-6/20260102071557/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/statement-classification-insulin-products-duration-action-notice-stakeholders.html#ha_snapshot=432103","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}